179 related articles for article (PubMed ID: 28782845)
1. Alpha-synuclein triggers T-cell response. Is Parkinson's disease an autoimmune disorder?
Bandres-Ciga S; Cookson MR
Mov Disord; 2017 Sep; 32(9):1327. PubMed ID: 28782845
[No Abstract] [Full Text] [Related]
2. Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease.
Caggiu E; Paulus K; Galleri G; Arru G; Manetti R; Sechi GP; Sechi LA
J Neuroimmunol; 2017 Sep; 310():26-31. PubMed ID: 28778441
[TBL] [Abstract][Full Text] [Related]
3. T cells from patients with Parkinson's disease recognize α-synuclein peptides.
Sulzer D; Alcalay RN; Garretti F; Cote L; Kanter E; Agin-Liebes J; Liong C; McMurtrey C; Hildebrand WH; Mao X; Dawson VL; Dawson TM; Oseroff C; Pham J; Sidney J; Dillon MB; Carpenter C; Weiskopf D; Phillips E; Mallal S; Peters B; Frazier A; Lindestam Arlehamn CS; Sette A
Nature; 2017 Jun; 546(7660):656-661. PubMed ID: 28636593
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
Garretti F; Agalliu D; Lindestam Arlehamn CS; Sette A; Sulzer D
Front Immunol; 2019; 10():303. PubMed ID: 30858851
[TBL] [Abstract][Full Text] [Related]
5. Timing Is Everything: The T-Cell Response to α-Synuclein Is Maximal in Early Parkinson's.
Kouli A; Williams-Gray CH
Mov Disord; 2020 Jul; 35(7):1137. PubMed ID: 32557803
[No Abstract] [Full Text] [Related]
6. Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases.
Lindestam Arlehamn CS; Garretti F; Sulzer D; Sette A
Curr Opin Immunol; 2019 Aug; 59():115-120. PubMed ID: 31430650
[TBL] [Abstract][Full Text] [Related]
7. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432
[TBL] [Abstract][Full Text] [Related]
8. The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.
Pavlou MAS; Pinho R; Paiva I; Outeiro TF
Brain; 2017 Apr; 140(4):878-886. PubMed ID: 27585855
[TBL] [Abstract][Full Text] [Related]
9. Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease?
Caggiu E; Paulus K; Arru G; Piredda R; Sechi GP; Sechi LA
J Neuroimmunol; 2016 Feb; 291():110-4. PubMed ID: 26857504
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O
Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206
[TBL] [Abstract][Full Text] [Related]
11. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.
Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A
Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
[TBL] [Abstract][Full Text] [Related]
15. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
Koo HJ; Choi MY; Im H
Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein and Lewy pathology in Parkinson's disease.
Kalia LV; Kalia SK
Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807
[TBL] [Abstract][Full Text] [Related]
17. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
Pozo Devoto VM; Falzone TL
Dis Model Mech; 2017 Sep; 10(9):1075-1087. PubMed ID: 28883016
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
Blanz J; Saftig P
J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.
Drouin-Ouellet J; St-Amour I; Saint-Pierre M; Lamontagne-Proulx J; Kriz J; Barker RA; Cicchetti F
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]